Wellington company Wellumio is a finalist in this year's KiwiNet Awards which celebrate the union of scientific research with commercial opportunity.
Wellumio has created a portable device that can detect strokes at the first point of care e.g. in an ambulance. With an estimated 9500 New Zealanders suffering a stroke every year and tens of millions worldwide, it has the potential to not only improve patient outcomes but to save billions in healthcare costs globally.
The first human clinical trial of the device is currently being run at The Royal Melbourne Hospital.
Co-founder, Dr. Shieak Tzeng explains to Susie how it works and when they hope to get it to market.
Find the full article here.
.jpg)